<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5210076 Figure_1-A</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Flow-cytometry for CD1d expression (top) and CD1d mean fluorescence intensity (MFI; bottom) on CD45- cells, ILCs (Lin-CD45+CD127+), DCs (CD11c+) and B cells (B220+) of the depicted tissues from WT mice (n=4).</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_1-B</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Flow-cytometry profiles showing gating strategy (dot-plots), CD1d expression (histograms) and CD1d MFI (bars) in T-bet+ (empty profile), GATA-3+ (dark grey), ROR&#947;t+ (light grey) and T-bet+ROR&#947;t+ (dotted line) ILCs in mLN, spleen, PP and SI-LP (n=5). Numbers indicate percentage of cells in the depicted gates.</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_1-C</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Quantitative RT-PCR analysis of mRNA encoding CD1d in freshly isolated ILC3s (from mLN of CD1d-deficient mice and mLN and spleen of WT mice), B cells and DCs (n=3). Results are normalized to those of GAPDH; RE=relative expression. **p&lt; 0.01 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_1-D</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Flow-cytometry profiles showing NKp46 and ROR&#947;t expression in Lin-CD45+cells; CD1d and CCR6 expression in NCR-ILC3s and CD1d and CD4 expression in NCR-CCR6+ILC3s from mLN and SI-LP (n=4). Numbers indicate percentage of cells in the depicted gates.</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_1-E</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) CD1d expression (histograms) and CD1d MFI in NCR+ (empty profile), NCR-CCR6- (dark grey) and NCR-CCR6+ (light grey) ILC3s from mLN and SI-LP (n=4).</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_2-A</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Cells were cultured in the presence or absence of BODIPY-&#945;GalCer at 4oC or 37oC as indicated. Flow cytometry profiles and percentages of BODIPY-&#945;GalCer+ DC or ILC3 from the indicated tissues incubated at 4oC (white bars) or 37oC (grey bars) are shown (n=3).</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_2-B</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) WT mice were intravenously injected with BODIPY-&#945;GalCer or PBS (control); lipid uptake was analysed by flow-cytometry in the depicted populations from the spleen 16 h after lipid injection (n=3). Numbers indicate percentage of cells in the depicted gates.</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_2-C</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) IL-2 secretion by DN32.D3 cells co-cultured with ILC3 sort-purified from mLN or spleen as indicated, pulsed (+) or not (-) with &#945;GalCer and with or without antiCD1d-blocking antibody.</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_2-E</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) Sort-purified ILC3s were preincubated with &#945;GalCer (ILC3(&#945;Gal)) or PBS (ILC3(cont)) and adoptively transferred into WT recipients. (E) Fold change in mRNA expression for the indicated cytokines in iNKT cells sort-purified from spleen, mLN or SI-LP of mice injected with &#945;GalCer-loaded ILC3s. Gene expression was measured by qPCR, normalized to GAPDH and presented as expression relative to iNKT cells sort-purified from mice injected with control ILC3s (n=3-5).</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_2-F</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) Sort-purified ILC3s were preincubated with &#945;GalCer (ILC3(&#945;Gal)) or PBS (ILC3(cont)) and adoptively transferred into WT recipients. (F) Intracellular cytokine staining (left) and percentage of cytokine+ cells (right) in spleniciNKT cells from ILC3-recipient mice (n=3). Numbers indicate percentage of cells in the depicted gates. **p&lt;0.01, two-tailed unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_3-A</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A-B) Flow-cytometry plots showing gating strategy (A) and percentage of ILC populations (from Lin-CD45+CD127+cells, B) in mLN from WT (n=4) and CD1d-deficient (n=3) mice.</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_3-B</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A-B) Flow-cytometry plots showing gating strategy (A) and percentage of ILC populations (from Lin-CD45+CD127+cells, B) in mLN from WT (n=4) and CD1d-deficient (n=3) mice.</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_3-C</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Fold change in mRNA expression for the indicated cytokines in ILC3s after antibody-mediated CD1d crosslink (n=3). Gene expression was measured by qPCR and normalized to GAPDH and to the mRNA expression levels in control ILC3s. *p&lt;0.05 two-tailed unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_3-D</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Fold change in IL22 mRNA expression in ILC3s after antibody-mediated CD1d crosslink and/or IL-23 stimulation (n=4). Gene expression was measured by qPCR and normalized to GAPDH and to the mRNA expression levels in control ILC3s. **p&lt;0.01 two-tailed unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_3-E</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) IL-22 detection by ELISA in the supernatant of ILC3s cultured in the presence of &#945;CD1d and/or IL-23 (n=3). *p&lt;0.05 two-tailed unpaired t-test</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_3-F-G</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 3-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>(F-G) Intracellular cytokine staining (F) and percentage of IL-22+ILC3s (G) after stimulation with &#945;CD1d, IL-23 and/or IL-1&#946;. *p&lt;0.05, **p&lt;0.01 two-tailed unpaired t-test (n=4-8)</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_3-H</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 3-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) WT mice were i.v. injected with &#945;GalCer or PBS (control) and activation of splenicILC3s was assessed by flow-cytometry as CD69 up-regulation at 6 h or 16 h after injection. Grey filled profile= ILC3 from &#945;GalCer-injected mice; Empty profile= ILC3 from PBS-injected mice; Dotted line= CD45-cells. Right graph, percentage of CD69+ILC3s 6 h after injection of &#945;GalCer (grey) or PBS (white). (n=3) *p&lt;0.05 two-tailed unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>5210076 Figure_3-I-J</id>
    <infon key="sourcedata_document">2451</infon>
    <infon key="doi">10.15252/embr.201642412</infon>
    <infon key="pmc_id">5210076</infon>
    <infon key="figure">Figure 3-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_3-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>(I-J) Fold change in mRNA expression for the indicated cytokines in ILC3s sort-purified from spleen (I) or SI-LP (J) 6 h after intravenous (I) or oral (J) &#945;Galcer administration. Gene expression was measured by qPCR and normalized to GAPDH and to the expression levels in ILC3s sort-purified from PBS-injected mice (n=3). *p&lt;0.05, **p&lt;0.01 two-tailed unpaired t-test.</text>
    </passage>
  </document>
</collection>
